Mammalian target of rapamycin (mTOR) kinase inhibitors
Everolimus
The FDA lists this product in 60 strengths and forms.
Composition
- Active ingredients
- EVEROLIMUS 0.75MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- EVEROLIMUS 0.75MG · TabletThis page
- EVEROLIMUS 0.25MG · TabletANDA205432-001 · Prescription
- EVEROLIMUS 1MG · TabletANDA205432-004 · Prescription
- EVEROLIMUS 0.5MG · TabletANDA205432-002 · Prescription
- EVEROLIMUS 1MG · TabletANDA214138-004 · Prescription
- EVEROLIMUS 0.5MG · TabletANDA214138-002 · Prescription
- EVEROLIMUS 0.75MG · TabletANDA214138-003 · Prescription
- EVEROLIMUS 0.25MG · TabletANDA214138-001 · Prescription
- EVEROLIMUS 10MG · TabletANDA214182-004 · Prescription
- EVEROLIMUS 5MG · TabletANDA214182-002 · Prescription
- EVEROLIMUS 7.5MG · TabletANDA214182-003 · Prescription
- EVEROLIMUS 2.5MG · TabletANDA214182-001 · Prescription
- EVEROLIMUS 3MG · Tablet, for suspension